In the current study, we diagnosed patients with early pSS using a simplified scoring system and investigated the clinical manifestation and serum cytokine release, such as IL-17, IL-18, IL-25, IL-31, and IL-33, in patients. This evidence concerns the gene IL17A and peeling skin syndrome.